Trial Details

Recruiting
Basic Information
Clinical ID c3119
Identifier ACTRN12613001292763
Trial Title Predicting response to biologics in inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Inflammatory bowel disease; Inflammatory bowel disease;Oral and Gastrointestinal - Inflammatory bowel disease
Interventions This is an observational study. Patients receiving biologic therapy for treatment of inflammatory bowel disease will be recruited. Disease activity will be recorded prior to therapy and during therapy. Blood samples will be collected just prior to a dose to measure concentrations of biologic drug and anti-drug antibodies, and both will be correlated with disease activity. This includes CDAI, HBI and SCCAI. Patients will be seen for blood samples and to record disease activity on between 1 or 3 occasions after starting therapy, after at least 12 weeks of therapy, when they are failing therapy and again if they change to a second biologic drug, after at least 12 weeks.
Participant Information
Sponsor University of Otago Christchurch
City -
Country/Region New Zealand
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -